Share
CBS News
A long-awaited coronavirus vaccine could be available in roughly two months, according to drugmaker AstraZeneca, which is developing a treatment.
The Anglo-Swedish drugmaker is working with the University of Oxford to develop one of the most closely watched COVID-19 vaccines, which is in late stage trials in the U.S., the U.K. and other countries to determine its safety and effectiveness. Once those results are reported, regulators will have to approve the vaccine for widespread use.
AstraZeneca said it will analyze data from its vaccine trials in November and December. If the results look promising, it will move quickly to ramp up manufacturing and obtain government approval in the U.S. and elsewhere, Chief Executive Pascal Soriot said Thursday.
RELATED TOPICS:
Categories
A Far-Right German EU Lawmaker’s Aide Is Arrested on Suspicion of Spying for China
Wall Street Rallies and Adds to Its Hot Start to the Week
Newsom Criticizes Local Response to Homelessness. He Should Look in the Mirror.
Google Fires More Workers Who Protested Its Deal With Israel
Winn Sharp Again, Conforto Homers as Giants Clip Mets
CA Lawmakers Reject Bill Cracking Down on Utilities Spending Customers’ Money
